Arcutis Biotherapeutics, Inc. (ARQT) market cap

Market cap today
$3.46B

Arcutis Biotherapeutics, Inc. (ARQT) has a market cap of $3.46B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.69B. That is 119.3% higher than the $1.68B of fiscal 2024. Today's figure is 6.5% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$3.46B
Market cap, fiscal 2025
$3.69B
Change on fiscal 2024
+119.3%
Growth, 5 years
+29.8% a year
Highest on record
$3.69Bfiscal 2025
Lowest on record
$223.86Mfiscal 2023
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arcutis Biotherapeutics, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 29.8% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $3.69B in fiscal 2025 and the lowest $223.86M in fiscal 2023.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Arcutis Biotherapeutics, Inc. market cap, year by year

Arcutis Biotherapeutics, Inc. (ARQT) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$3.46B—$27.33—
2025$3.69B 119.3% up$29.04127.23M
2024$1.68B 652.7% up$13.93120.96M
2023$223.86M 72.5% down$3.2369.31M
2022$814.48M 20.5% down$14.8055.03M
2021$1.02B 2.1% up$20.7449.41M
2020$1.00B—$28.1335.67M
2019———1.84M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on ARQT

Arcutis Biotherapeutics, Inc., figure by figure

Arcutis Biotherapeutics, Inc. (ARQT) overview: price, valuation and scorecard

Arcutis Biotherapeutics, Inc. market cap: questions and answers

What is Arcutis Biotherapeutics, Inc.'s market cap?

Arcutis Biotherapeutics, Inc. (ARQT) has a market cap of $3.46B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.69B. That is 119.3% higher than the $1.68B of fiscal 2024.

What is the growth rate of Arcutis Biotherapeutics, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 29.8% a year.

What are the highest and lowest market cap figures on record for Arcutis Biotherapeutics, Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $3.69B in fiscal 2025 and the lowest $223.86M in fiscal 2023.

How is Arcutis Biotherapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Arcutis Biotherapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arcutis Biotherapeutics, Inc. (ARQT) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/ARQT/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.